Clinical Trial

18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 21, 2023 (before its estimated June 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to explore whether 18F-FDG PET/CT guided reduced-dose radiotherapy would maintain survival outcomes in nasopharyngeal carcinoma (NPC) patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-03-22; most recent amendment 2023-02-17.
Status change: Not Yet Recruiting → Recruiting 2023-02-17
Trial Details
NCT Number NCT04813705
Lead Sponsor Taizhou Hospital
Collaborators: Taizhou Enze Medical Center Group, Taizhou Cancer Hospital
Conditions Nasopharyngeal Carcinoma
Enrollment 93 participants
Start Date 2022-01-01
Primary Completion 2024-06-30 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2023-02-21